- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 279/14 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
Patent holdings for IPC class C07C 279/14
Total number of patents in this class: 245
10-year publication summary
|
21
|
18
|
23
|
26
|
21
|
24
|
31
|
18
|
15
|
9
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alzchem Trostberg GmbH | 262 |
11 |
| ARK Diagnostics, Inc. | 34 |
7 |
| ThermoLife International, LLC | 116 |
5 |
| Evonik Operations GmbH | 3959 |
5 |
| Inspirna, Inc. | 35 |
5 |
| Colgate-Palmolive Company | 5756 |
4 |
| Massachusetts Institute of Technology | 9931 |
4 |
| Arena Pharmaceuticals, Inc. | 366 |
4 |
| Satiogen Pharmaceuticals, Inc. | 13 |
4 |
| Mesosil Inc. | 7 |
4 |
| The Regents of the University of California | 19661 |
3 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10729 |
3 |
| Evologie, LLC | 9 |
3 |
| Exerkine Corporation | 33 |
3 |
| Farmington Pharma Development | 7 |
3 |
| Giuliani S.p.A. | 302 |
3 |
| Newsouth Innovations Pty Limited | 591 |
3 |
| Sekisui Medical Co., Ltd. | 651 |
3 |
| Signature Therapeutics, Inc. | 37 |
3 |
| Jiangsu Yuanyang Pharmaceutical Co., Ltd. | 4 |
3 |
| Other owners | 162 |